Sakakibara N - Search Results

1

Amodiaquine derivatives as inhibitors of severe fever with thrombocytopenia syndrome virus (SFTSV) replication.

Baba M, Okamoto M, Toyama M, Sakakibara N, Shimojima M, Saijo M, Niwa T, Yagi Y. Baba M, et al. Among authors: sakakibara n. Antiviral Res. 2023 Feb;210:105479. doi: 10.1016/j.antiviral.2022.105479. Epub 2022 Dec 22. Antiviral Res. 2023. PMID: 36566117 Free article.

2

Establishment of an antiviral assay system and identification of severe fever with thrombocytopenia syndrome virus inhibitors.

Baba M, Toyama M, Sakakibara N, Okamoto M, Arima N, Saijo M. Baba M, et al. Among authors: sakakibara n. Antivir Chem Chemother. 2017 Dec;25(3):83-89. doi: 10.1177/2040206617740303. Epub 2017 Nov 3. Antivir Chem Chemother. 2017. PMID: 29096526 Free PMC article.

3

Novel amodiaquine derivatives potently inhibit Ebola virus infection.

Sakurai Y, Sakakibara N, Toyama M, Baba M, Davey RA. Sakurai Y, et al. Among authors: sakakibara n. Antiviral Res. 2018 Dec;160:175-182. doi: 10.1016/j.antiviral.2018.10.025. Epub 2018 Nov 3. Antiviral Res. 2018. PMID: 30395872 Free PMC article.

4

Design, synthesis, and anti-HIV-1 activity of 1-aromatic methyl-substituted 3-(3,5-dimethylbenzyl)uracil and N-3,5-dimethylbenzyl-substituted urea derivatives.

Sakakibara N, Baba M, Okamoto M, Toyama M, Demizu Y, Misawa T, Kurihara M, Irie K, Kato Y, Maruyama T. Sakakibara N, et al. Antivir Chem Chemother. 2015 Feb;24(1):3-18. doi: 10.1177/2040206614566584. Antivir Chem Chemother. 2015. PMID: 26149262 Free PMC article.

5

Design, synthesis, and anti-HIV-1 activity of 1-substituted 3-(3,5-dimethylbenzyl)triazine derivatives.

Sakakibara N, Balboni G, Congiu C, Onnis V, Demizu Y, Misawa T, Kurihara M, Kato Y, Maruyama T, Toyama M, Okamoto M, Baba M. Sakakibara N, et al. Antivir Chem Chemother. 2015 Apr;24(2):62-71. doi: 10.1177/2040206615612208. Epub 2015 Oct 28. Antivir Chem Chemother. 2015. PMID: 26514833 Free PMC article.

6

Pyrimidotriazine derivatives as selective inhibitors of HBV capsid assembly.

Toyama M, Sakakibara N, Takeda M, Okamoto M, Watashi K, Wakita T, Sugiyama M, Mizokami M, Ikeda M, Baba M. Toyama M, et al. Among authors: sakakibara n. Virus Res. 2019 Oct 2;271:197677. doi: 10.1016/j.virusres.2019.197677. Epub 2019 Jul 31. Virus Res. 2019. PMID: 31376401

7

Synthesis of 1-benzyl-3-(3,5-dimethylbenzyl)uracil derivatives with potential anti-HIV activity.

Isono Y, Sakakibara N, Ordonez P, Hamasaki T, Baba M, Ikejiri M, Maruyama T. Isono Y, et al. Among authors: sakakibara n. Antivir Chem Chemother. 2011 Oct 7;22(2):57-65. doi: 10.3851/IMP1844. Antivir Chem Chemother. 2011. PMID: 21984685 Free article.

8

Anti-human immunodeficiency virus type 1 activity of novel 6-substituted 1-benzyl-3-(3,5-dimethylbenzyl)uracil derivatives.

Ordonez P, Hamasaki T, Isono Y, Sakakibara N, Ikejiri M, Maruyama T, Baba M. Ordonez P, et al. Among authors: sakakibara n. Antimicrob Agents Chemother. 2012 May;56(5):2581-9. doi: 10.1128/AAC.06307-11. Epub 2012 Jan 30. Antimicrob Agents Chemother. 2012. PMID: 22290950 Free PMC article.

9

Synthesis and evaluation of novel 3-(3,5-dimethylbenzyl)uracil analogs as potential anti-HIV-1 agents.

Sakakibara N, Hamasaki T, Baba M, Demizu Y, Kurihara M, Irie K, Iwai M, Asada E, Kato Y, Maruyama T. Sakakibara N, et al. Bioorg Med Chem. 2013 Sep 15;21(18):5900-6. doi: 10.1016/j.bmc.2013.06.061. Epub 2013 Jul 3. Bioorg Med Chem. 2013. PMID: 23916148

10

[Synthesis and evaluation of novel nucleic acid derivatives as bioactive substances].

Sakakibara N. Sakakibara N. Yakugaku Zasshi. 2014;134(9):965-72. doi: 10.1248/yakushi.14-00175. Yakugaku Zasshi. 2014. PMID: 25174367 Free article. Review. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

370 results

Search Page